Trial Site Detail

 

Drug:
osi-930
Trial:
Phase 1 Study of OSI-930 in Cancer Patients
Conditions: Solid Tumors Sarcoma
Trial Status:
Completed

 

Department of Cancer Therapeutics, Institute of Cancer Research

Downs Rd     
Sutton , Surrey SM2 5PT
UK

 

Principal Investigator:
Contact:
+44-0-20-8722-4302 royalmarsden.org
Activation Status of this Site:
Closed
Notes about this Site:
Department of Cancer Therapeutics, Institute of Cancer Research Website:
http://www.icr.ac.uk/research/research_sections/cancer_therapeutics/cancer_therapeutics_teams/clinical_pharmacology_and_trials/studies_with_cancer_research_uk/1689.shtml

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.